Home > Drug Search >
  • company_query: Amphastar
  •   > 
Drug Filter
Category:
chemistry (4) biology (22)
Status:
Approved (6) Phase Ⅲ (5) Phase Ⅱ (6) Phase Ⅰ (8) IND Filing (1)
Clinical Stage:
Pending (1) Active (16) Discontinued (2)
Bio-Type:
Gene therapy (3) Cell therapy (1) CAR T cell therapy (4) Vaccine (3) Blood extraction (3) Whole antibody (5) ADC (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Chronic pain (1) Crohn's disease (1) Transplant rejection (1) Gastric cancer (1) Opioid central depression (1) Hypovolemia (1) Hypoalbuminemia (1) Ovarian hyperstimulation syndrome (OHSS) (1) Adult respiratory distress syndrome (ADRS) (1) Cardiopulmonary bypass (1) HIV infection (1) Influenza virus infection (1) Chronic inflammatory demyelinating polyradiculoneuropathy (1) Rabies (2) Type I plasminogen deficiency (1) Leukemia (1) Melanoma (1) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (1) Hemophagocytic lymphohistiocytosis (1) Solid tumours (3) Helicobacter pylori infection (1) Neuroblastoma (1) Sarcoma (1) Diagnostic agents (1) Hemophilia B (1) Autoimmune diseases (2) Glioma (1) Burns (1) Skin hypertrophic scars (1) Immunodeficiency disorders (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top